01.03.2013 | Short Communication | Ausgabe 1/2013

Pegylated liposomal doxorubicin as third-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: results of a phase II study
- Zeitschrift:
- Medical Oncology > Ausgabe 1/2013